Kidney or Thyroid Cancer

EAQ191 / CARISMA


Cancer Therapy Risk-Reduction with Intensive Systolic BP Management (CARISMA)-A Phase II Study

Physician and Research Staff Educational Material

This material is intended for promotional use among health care professionals and is NOT intended for use as patient educational material. Scroll down for patient educational material.



Patient Educational Material

Participating sites should note that the Central Institutional Review Board (CIRB) has approved this material.

ECOG-ACRIN Cancer Research Group